Why It's Not Too Late to Buy Agenus, Inc. Stock
Small-cap biotech Agenus has seen its share price roar higher since acquiring some highly prized assets in immuno-oncology. Here's why this stock could push even higher going forward.
Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Years
Big Pharma stocks often have deep product pipelines, substantial cash flow, and healthy dividends, but they are far from created equal. With patent expirations taking their toll, this would appear to be the one Big Pharma stock you can trust over the next decade.
3 Little-Known Biotechs Working On Potential Blockbusters
These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.
Could These Experimental Drugs Eclipse Harvoni's Historic Launch?
Harvoni set the standard for blockbuster drug launches -- but these three drugs just might have a shot at being even bigger.
After Hours Most Active for Mar 26, 2015 : V, BAC, BBD, WFC, PFE, HOT, GMCR, QQQ, CMCSA, FB, CSCO,
After Hours Most Active for Mar 26, 2015 : V, BAC, BBD, WFC, PFE, HOT, GMCR, QQQ, CMCSA, FB, CSCO, AAPL